Loading…
Reported covered position: Confidential Assistant, Department of Commerce
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Healthcare supply chain and resiliency, issues related to federal Medicare/Medicaid reimbursement for medical products, DMEPOS Relief Act of 2025/Competitive Bidding Relief Act (H.R. 2005/S. 2951), Choices For Increased Mobility Act (H.R. 1703/S. 247), Supplemental Oxygen Access Reform Act of 2025 (H.R. 2902/S. 1406), Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services (DIABETES) Act (S. 4037), The Medicare Advantage Improvement Act of 2026 (S. 4384/H.R. 8375), The Improving Access to Medicare Coverage Act (S. 4641/H.R. 3954), The Ensuring Seniors Access to Quality Care Act (S.4467/H.R. 7096)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
Issues related to tariffs and healthcare supply chain
Healthcare supply chain and resiliency, issues related to federal Medicare/Medicaid reimbursement for medical products
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Intl Trade Administration (ITA), Natl Economic Council (NEC), SENATE, U.S. Trade Representative (USTR), White House Office
Source: Senate LDA
Healthcare supply chain and resiliency, issues related to federal Medicare/Medicaid reimbursement for medical products, DMEPOS Relief Act of 2025/Competitive Bidding Relief Act (H.R. 2005/S. 2951), Choices For Increased Mobility Act (H.R. 1703/S. 247), Supplemental Oxygen Access Reform Act of 2025 (H.R. 2902/S. 1406), Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services (DIABETES) Act (S. 4037), The Medicare Advantage Improvement Act of 2026 (S. 4384/H.R. 8375), The Improving Access to Medicare Coverage Act (S. 4641/H.R. 3954), The Ensuring Seniors Access to Quality Care Act (S.4467/H.R. 7096)
Healthcare supply chain and resiliency, issues related to federal Medicare/Medicaid reimbursement for medical products, DMEPOS Relief Act of 2025/Competitive Bidding Relief Act (H.R. 2005/S. 2951), Choices For Increased Mobility Act (H.R. 1703/S. 247), Supplemental Oxygen Access Reform Act of 2025 (H.R. 2902/S. 1406), Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services (DIABETES) Act (S. 4037), The Medicare Advantage Improvement Act of 2026 (S. 4384/H.R. 8375), The Improving Access to Medicare Coverage Act (S. 4641/H.R. 3954), The Ensuring Seniors Access to Quality Care Act (S.4467/H.R. 7096)
Healthcare supply chain and resiliency, issues related to federal Medicare/Medicaid reimbursement for medical products, DMEPOS Relief Act of 2025/Competitive Bidding Relief Act (H.R. 2005/S. 2951), Choices For Increased Mobility Act (H.R. 1703/S. 247), Supplemental Oxygen Access Reform Act of 2025 (H.R. 2902/S. 1406), Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services (DIABETES) Act (S. 4037), The Medicare Advantage Improvement Act of 2026 (S. 4384/H.R. 8375), The Improving Access to Medicare Coverage Act (S. 4641/H.R. 3954), The Ensuring Seniors Access to Quality Care Act (S.4467/H.R. 7096)
Healthcare supply chain and resiliency, issues related to federal Medicare/Medicaid reimbursement for medical products, DMEPOS Relief Act of 2025/Competitive Bidding Relief Act (H.R. 2005/S. 2951), Choices For Increased Mobility Act (H.R. 1703/S. 247), Supplemental Oxygen Access Reform Act of 2025 (H.R. 2902/S. 1406), Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services (DIABETES) Act (S. 4037), The Medicare Advantage Improvement Act of 2026 (S. 4384/H.R. 8375), The Improving Access to Medicare Coverage Act (S. 4641/H.R. 3954), The Ensuring Seniors Access to Quality Care Act (S.4467/H.R. 7096)
Healthcare supply chain and resiliency, issues related to federal Medicare/Medicaid reimbursement for medical products, DMEPOS Relief Act of 2025/Competitive Bidding Relief Act (H.R. 2005/S. 2951), Choices For Increased Mobility Act (H.R. 1703/S. 247), Supplemental Oxygen Access Reform Act of 2025 (H.R. 2902/S. 1406), Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services (DIABETES) Act (S. 4037), The Medicare Advantage Improvement Act of 2026 (S. 4384/H.R. 8375), The Improving Access to Medicare Coverage Act (S. 4641/H.R. 3954), The Ensuring Seniors Access to Quality Care Act (S.4467/H.R. 7096)
Healthcare supply chain and resiliency, issues related to federal Medicare/Medicaid reimbursement for medical products, DMEPOS Relief Act of 2025/Competitive Bidding Relief Act (H.R. 2005/S. 2951), Choices For Increased Mobility Act (H.R. 1703/S. 247), Supplemental Oxygen Access Reform Act of 2025 (H.R. 2902/S. 1406), Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services (DIABETES) Act (S. 4037), The Medicare Advantage Improvement Act of 2026 (S. 4384/H.R. 8375), The Improving Access to Medicare Coverage Act (S. 4641/H.R. 3954), The Ensuring Seniors Access to Quality Care Act (S.4467/H.R. 7096)
Healthcare supply chain and resiliency, issues related to federal Medicare/Medicaid reimbursement for medical products, DMEPOS Relief Act of 2025/Competitive Bidding Relief Act (H.R. 2005/S. 2951), Choices For Increased Mobility Act (H.R. 1703/S. 247), Supplemental Oxygen Access Reform Act of 2025 (H.R. 2902/S. 1406), Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services (DIABETES) Act (S. 4037), The Medicare Advantage Improvement Act of 2026 (S. 4384/H.R. 8375), The Improving Access to Medicare Coverage Act (S. 4641/H.R. 3954), The Ensuring Seniors Access to Quality Care Act (S.4467/H.R. 7096)
Healthcare supply chain and resiliency, issues related to federal Medicare/Medicaid reimbursement for medical products, DMEPOS Relief Act of 2025/Competitive Bidding Relief Act (H.R. 2005/S. 2951), Choices For Increased Mobility Act (H.R. 1703/S. 247), Supplemental Oxygen Access Reform Act of 2025 (H.R. 2902/S. 1406), Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services (DIABETES) Act (S. 4037), The Medicare Advantage Improvement Act of 2026 (S. 4384/H.R. 8375), The Improving Access to Medicare Coverage Act (S. 4641/H.R. 3954), The Ensuring Seniors Access to Quality Care Act (S.4467/H.R. 7096)
Healthcare supply chain and resiliency, issues related to federal Medicare/Medicaid reimbursement for medical products, DMEPOS Relief Act of 2025/Competitive Bidding Relief Act (H.R. 2005/S. 2951), Choices For Increased Mobility Act (H.R. 1703/S. 247), Supplemental Oxygen Access Reform Act of 2025 (H.R. 2902/S. 1406), Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services (DIABETES) Act (S. 4037), The Medicare Advantage Improvement Act of 2026 (S. 4384/H.R. 8375), The Improving Access to Medicare Coverage Act (S. 4641/H.R. 3954), The Ensuring Seniors Access to Quality Care Act (S.4467/H.R. 7096)
Healthcare supply chain and resiliency, issues related to federal Medicare/Medicaid reimbursement for medical products, DMEPOS Relief Act of 2025/Competitive Bidding Relief Act (H.R. 2005/S. 2951), Choices For Increased Mobility Act (H.R. 1703/S. 247), Supplemental Oxygen Access Reform Act of 2025 (H.R. 2902/S. 1406), Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services (DIABETES) Act (S. 4037), The Medicare Advantage Improvement Act of 2026 (S. 4384/H.R. 8375), The Improving Access to Medicare Coverage Act (S. 4641/H.R. 3954), The Ensuring Seniors Access to Quality Care Act (S.4467/H.R. 7096)
Healthcare supply chain and resiliency, issues related to federal Medicare/Medicaid reimbursement for medical products, DMEPOS Relief Act of 2025/Competitive Bidding Relief Act (H.R. 2005/S. 2951), Choices For Increased Mobility Act (H.R. 1703/S. 247), Supplemental Oxygen Access Reform Act of 2025 (H.R. 2902/S. 1406), Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services (DIABETES) Act (S. 4037), The Medicare Advantage Improvement Act of 2026 (S. 4384/H.R. 8375), The Improving Access to Medicare Coverage Act (S. 4641/H.R. 3954), The Ensuring Seniors Access to Quality Care Act (S.4467/H.R. 7096)
Healthcare supply chain and resiliency, issues related to federal Medicare/Medicaid reimbursement for medical products, DMEPOS Relief Act of 2025/Competitive Bidding Relief Act (H.R. 2005/S. 2951), Choices For Increased Mobility Act (H.R. 1703/S. 247), Supplemental Oxygen Access Reform Act of 2025 (H.R. 2902/S. 1406), Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services (DIABETES) Act (S. 4037), The Medicare Advantage Improvement Act of 2026 (S. 4384/H.R. 8375), The Improving Access to Medicare Coverage Act (S. 4641/H.R. 3954), The Ensuring Seniors Access to Quality Care Act (S.4467/H.R. 7096)
Safeguarding America's Pharmaceuticals Act of 2013
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Issues related to pharmaceutical supply chain security including H.R. 1919 - Safeguarding America's Pharmaceuticals Act and S. 957 - Drug Supply Chain Security Act; Issues related to the medical device tax, including H.R. 523 - Protect Medical Innovation Act of 2013.
Protect Medical Innovation Act of 2013
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Issues related to the FDA; Issues related to pharmaceutical supply chain security; Issues related to cosmetics; Issues related to the medical device tax, including H.R. 523 - Protect Medical Innovation Act of 2013.
Protect Medical Innovation Act of 2013
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Issues related to pharmaceutical supply chain security including H.R. 1919 - Safeguarding America's Pharmaceuticals Act and S. 957 - Drug Supply Chain Security Act; Issues related to the medical device tax, including H.R. 523 - Protect Medical Innovation Act of 2013.
Drug Supply Chain Security Act
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Issues related to pharmaceutical supply chain security including H.R. 1919 - Safeguarding America's Pharmaceuticals Act and S. 957 - Drug Supply Chain Security Act; Issues related to the medical device tax, including H.R. 523 - Protect Medical Innovation Act of 2013.
Safe Cosmetics Act of 2011
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Issues related to the FDA; Issues related to pharmaceutical supply chain security; Issues related to cosmetics, including H.R. 4395 - Cosmetic Safety Amendments Act of 2012 (as well as H.R. 2359 and H.R. 4262); Issues related to the medical device tax, including H.R. 436 - Health Care Cost Reduction Act of 2012 (as well as S. 17 and S. 262).
Safe Cosmetics Act of 2011
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Issues related to the FDA, including S. 3187 and H.R. 5651- Food and Drug Administration Safety and Innovation Act; Issues related to pharmaceutical supply chain security; Issues related to cosmetics, including H.R. 4395 - Cosmetic Safety Amendments Act of 2012 (as well as H.R. 2359 and H.R. 4262); Issues related to the medical device tax, including H.R. 436 - Health Care Cost Reduction Act of 2012 (as well as S. 17 and S. 262).
Safe Cosmetics Act of 2011
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Issues related to the FDA. Issues related to medical devices, including the Unique Device Identification System Proposed Rule; Issues related to pharmaceutical supply chain security; Issues related to cosmetics, including H.R. 4395 - Cosmetic Safety Amendments Act of 2012 (as well as H.R. 2359 and H.R. 4262); Issues related to the medical device tax, including H.R. 436 - Health Care Cost Reduction Act of 2012 (as well as S. 17 and S. 262).
Cosmetics Safety Enhancement Act of 2012
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Issues related to the FDA. Issues related to medical devices, including the Unique Device Identification System Proposed Rule; Issues related to pharmaceutical supply chain security; Issues related to cosmetics, including H.R. 4395 - Cosmetic Safety Amendments Act of 2012 (as well as H.R. 2359 and H.R. 4262); Issues related to the medical device tax, including H.R. 436 - Health Care Cost Reduction Act of 2012 (as well as S. 17 and S. 262).
Cosmetics Safety Enhancement Act of 2012
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Issues related to the FDA; Issues related to pharmaceutical supply chain security; Issues related to cosmetics, including H.R. 4395 - Cosmetic Safety Amendments Act of 2012 (as well as H.R. 2359 and H.R. 4262); Issues related to the medical device tax, including H.R. 436 - Health Care Cost Reduction Act of 2012 (as well as S. 17 and S. 262).
Cosmetics Safety Enhancement Act of 2012
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Issues related to the FDA, including S. 3187 and H.R. 5651- Food and Drug Administration Safety and Innovation Act; Issues related to pharmaceutical supply chain security; Issues related to cosmetics, including H.R. 4395 - Cosmetic Safety Amendments Act of 2012 (as well as H.R. 2359 and H.R. 4262); Issues related to the medical device tax, including H.R. 436 - Health Care Cost Reduction Act of 2012 (as well as S. 17 and S. 262).
Health Care Cost Reduction Act of 2012
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Issues related to the FDA, including S. 3187 and H.R. 5651- Food and Drug Administration Safety and Innovation Act; Issues related to pharmaceutical supply chain security; Issues related to cosmetics, including H.R. 4395 - Cosmetic Safety Amendments Act of 2012 (as well as H.R. 2359 and H.R. 4262); Issues related to the medical device tax, including H.R. 436 - Health Care Cost Reduction Act of 2012 (as well as S. 17 and S. 262).
Health Care Cost Reduction Act of 2012
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Issues related to the FDA. Issues related to medical devices, including the Unique Device Identification System Proposed Rule; Issues related to pharmaceutical supply chain security; Issues related to cosmetics, including H.R. 4395 - Cosmetic Safety Amendments Act of 2012 (as well as H.R. 2359 and H.R. 4262); Issues related to the medical device tax, including H.R. 436 - Health Care Cost Reduction Act of 2012 (as well as S. 17 and S. 262).
Health Care Cost Reduction Act of 2012
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Issues related to the FDA; Issues related to pharmaceutical supply chain security; Issues related to cosmetics, including H.R. 4395 - Cosmetic Safety Amendments Act of 2012 (as well as H.R. 2359 and H.R. 4262); Issues related to the medical device tax, including H.R. 436 - Health Care Cost Reduction Act of 2012 (as well as S. 17 and S. 262).
Cosmetic Safety Amendments Act of 2012
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Issues related to the FDA. Issues related to medical devices, including the Unique Device Identification System Proposed Rule; Issues related to pharmaceutical supply chain security; Issues related to cosmetics, including H.R. 4395 - Cosmetic Safety Amendments Act of 2012 (as well as H.R. 2359 and H.R. 4262); Issues related to the medical device tax, including H.R. 436 - Health Care Cost Reduction Act of 2012 (as well as S. 17 and S. 262).
Cosmetic Safety Amendments Act of 2012
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Issues related to the FDA; Issues related to pharmaceutical supply chain security; Issues related to cosmetics, including H.R. 4395 - Cosmetic Safety Amendments Act of 2012 (as well as H.R. 2359 and H.R. 4262); Issues related to the medical device tax, including H.R. 436 - Health Care Cost Reduction Act of 2012 (as well as S. 17 and S. 262).
Cosmetic Safety Amendments Act of 2012
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Issues related to the FDA, including S. 3187 and H.R. 5651- Food and Drug Administration Safety and Innovation Act; Issues related to pharmaceutical supply chain security; Issues related to cosmetics, including H.R. 4395 - Cosmetic Safety Amendments Act of 2012 (as well as H.R. 2359 and H.R. 4262); Issues related to the medical device tax, including H.R. 436 - Health Care Cost Reduction Act of 2012 (as well as S. 17 and S. 262).
Food and Drug Administration Reform Act of 2012
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Issues related to the FDA, including S. 3187 and H.R. 5651- Food and Drug Administration Safety and Innovation Act; Issues related to pharmaceutical supply chain security; Issues related to cosmetics, including H.R. 4395 - Cosmetic Safety Amendments Act of 2012 (as well as H.R. 2359 and H.R. 4262); Issues related to the medical device tax, including H.R. 436 - Health Care Cost Reduction Act of 2012 (as well as S. 17 and S. 262).
Healthcare supply chain and resiliency, issues related to federal Medicare/Medicaid reimbursement for medical products, DMEPOS Relief Act of 2025/Competitive Bidding Relief Act (H.R. 2005/S. 2951), Choices For Increased Mobility Act (H.R. 1703/S. 247), Supplemental Oxygen Access Reform Act of 2025 (H.R. 2902/S. 1406), Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services (DIABETES) Act (S. 4037), The Medicare Advantage Improvement Act of 2026 (S. 4384/H.R. 8375), The Improving Access to Medicare Coverage Act (S. 4641/H.R. 3954), The Ensuring Seniors Access to Quality Care Act (S.4467/H.R. 7096)
Issues related to tariffs and healthcare supply chain
Filing targets: Bureau of Industry and Security (BIS), Commerce, Dept of (DOC), Council of Economic Advisers (CEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Intl Trade Administration (ITA), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office
Healthcare supply chain and resiliency, issues related to medical device reprocessing, issues related to federal Medicare/Medicaid reimbursement for medical products
Issues related to tariffs and healthcare supply chain
Filing targets: Bureau of Industry and Security (BIS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Intl Trade Administration (ITA), SENATE
Healthcare supply chain and resiliency, issues related to medical provider reimbursement and federal funding for Medicaid and Medicare.
Issues related to tariffs and healthcare supply chain, reauthorization of the African Growth and Opportunity Act
Filing targets: Bureau of Industry and Security (BIS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Intl Trade Administration (ITA), SENATE, Treasury, Dept of, U.S. Customs & Border Protection, U.S. Trade Representative (USTR)
Issues related to the VA Medical/Surgical Prime Vendor Program
Healthcare supply chain and resiliency, medical device reprocessing, issues related to medical provider reimbursement and federal funding for Medicaid and Medicare.
Issues related to tariffs and healthcare supply chain, issues related to onshoring medical device production, reauthorization of the African Growth and Opportunity Act
Filing targets: Commerce, Dept of (DOC), Council of Economic Advisers (CEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Intl Trade Administration (ITA), Natl Economic Council (NEC), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office
MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP via MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
2013 · second_quarter · 2T
Issues related to pharmaceutical supply chain security including H.R. 1919 - Safeguarding America's Pharmaceuticals Act and S. 957 - Drug Supply Chain Security Act; Issues related to the medical device tax, including H.R. 523 - Protect Medical Innovation Act of 2013.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP via MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
2013 · first_quarter · Q1
Issues related to the FDA; Issues related to pharmaceutical supply chain security; Issues related to cosmetics; Issues related to the medical device tax, including H.R. 523 - Protect Medical Innovation Act of 2013.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP via MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
2012 · fourth_quarter · Q4
Issues related to the FDA; Issues related to pharmaceutical supply chain security; Issues related to cosmetics, including H.R. 4395 - Cosmetic Safety Amendments Act of 2012 (as well as H.R. 2359 and H.R. 4262); Issues related to the medical device tax, including H.R. 436 - Health Care Cost Reduction Act of 2012 (as well as S. 17 and S. 262).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP via MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
2012 · third_quarter · Q3
Issues related to the FDA. Issues related to medical devices, including the Unique Device Identification System Proposed Rule; Issues related to pharmaceutical supply chain security; Issues related to cosmetics, including H.R. 4395 - Cosmetic Safety Amendments Act of 2012 (as well as H.R. 2359 and H.R. 4262); Issues related to the medical device tax, including H.R. 436 - Health Care Cost Reduction Act of 2012 (as well as S. 17 and S. 262).
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP via MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
2012 · second_quarter · Q2
Issues related to the FDA, including S. 3187 and H.R. 5651- Food and Drug Administration Safety and Innovation Act; Issues related to pharmaceutical supply chain security; Issues related to cosmetics, including H.R. 4395 - Cosmetic Safety Amendments Act of 2012 (as well as H.R. 2359 and H.R. 4262); Issues related to the medical device tax, including H.R. 436 - Health Care Cost Reduction Act of 2012 (as well as S. 17 and S. 262).
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE
MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP via MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
2012 · second_quarter · RR
Issues related to the manufacturing and distribution of medical devices, pharmaceuticals, cosmetics, dietary supplements, and foods. Issues related to the manufacturing and distribution of textiles and furniture. Issues related to HHS (including the FDA), the EPA, the CPSC, DHS (including CBP), and USDA.